We need investment in precision medicine technologies to start programming cancer against itself, writes Cyriac Roeding.
Researchers at the MRC Laboratory of Medical Sciences (LMS) and Imperial College London have identified an overworked cog in ...
Northwestern Medicine scientists have uncovered an unexpected role for a well-known cancer-related protein, revealing a new layer of genetic regulation that could reshape how certain cancers are ...
Scientists are rethinking how to treat a widespread genetic cholesterol disorder by targeting particle production instead of removal.
Alida Biosciences today announced the launch of its EpiPlextm Tri-Modtm Service, enabling simultaneous detection and quantification of three key mRNA modifications?N6-methyladenosine (m6A), inosine, ...
SkinJect™ , a novel localized immuno-oncology precision product focused on non-melanoma skin diseases, especially basal cell carcinoma (BCC) and Gorlin Syndrome , a rare autosomal dominant disease ...
DNADX high scores predicted improved PFS, supporting genomic instability and DNA repair deficiency as biologically relevant ...
Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), a clinical-stage oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug ...
GenScript Biotech Corporation, the world's leading provider of CMOS-based DNA synthesis technologies, and Mimulus Corp, the ...
Cancer treatment has long relied on a largely fixed set of options: surgery, radiation, chemotherapy and targeted drugs. But ...
A specific protein controls mRNA transport in fungi and distinguishes important from unimportant binding sites in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results